Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

CIAN reported for 3 months of 2025 by RAS

5/23/25 CNRU

Board of Directors of OGK-2 recommended that dividends be paid for 2024

5/23/25 OGKB

Board of Directors of Territorial Generating Company № 1 recommended that dividends be paid for 2024

5/23/25 TGKA

ROSSETI North-West reported for 3 months of 2025 by IFRS

5/23/25 MRKZ

Sovcomflot posted a loss in the first quarter of 2025

5/23/25 FLOT

AFK System reported for 3 months of 2025 by RAS

5/23/25 AFKS

Yandex has agreed with MR Group to implement its AI in new buildings

5/23/25 YDEX

Board of Directors of Lambumiz recommended that dividends be paid for 2024

5/22/25 LMBZ

Gazprom will not pay dividends for 2024

5/22/25 GAZP

Ashinskiy Metallurgical Plant reported for 3 months of 2025 by RAS

5/22/25 AMEZ